Measurement of lung diffusion in cardiovascular disease

M. Guazzi (Milan, Italy)

Source: Annual Congress 2004 - PG13 - Lung diffusion measurements in diseases
Session: PG13 - Lung diffusion measurements in diseases
Session type: Postgraduate Course
Number: 77

Slide presentationPDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Guazzi (Milan, Italy). Measurement of lung diffusion in cardiovascular disease. Annual Congress 2004 - PG13 - Lung diffusion measurements in diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Measurement of lung diffusion in obstructive lung disease
Source: Annual Congress 2004 - PG13 - Lung diffusion measurements in diseases
Year: 2004


Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort
Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Year: 2007



Oxygen enhanced MRI biomarkers of lung function in interstitial lung disease
Source: Virtual Congress 2020 – Quantitative imaging in diffuse lung disease
Year: 2020




Short-term dynamic lung function and predictors of lung function decline in systemic sclerosis-related interstitial lung disease
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Prediction of chronic lung disease
Source: Eur Respir J 2003; 22: Suppl. 45, 139s
Year: 2003

Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015



Quantitative assessment of lung pathology in interstitial lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 243s
Year: 2001

Relationship between lung function disorders and condition of cardiovascular system in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 422s
Year: 2003

Pattern of diffusion disturbance in patients with interstitial lung diseases (ILDs)
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016


Investigation of relationships between inflammation and brain disease in COPD
Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities
Year: 2018




Risk assessment in severe pulmonary hypertension due to interstitial lung disease
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020


Monitoring of CF lung disease
Source: ERS course 2015
Year: 2015

Relationship between respiratory exchange ratio and pulmonary function in patients with obstructive lung disease
Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases
Year: 2021

Measurement of diffusion in pulmonary vascular disorders
Source: Annual Congress 2004 - PG13 - Lung diffusion measurements in diseases
Year: 2004


Siphonage lung disease
Source: Virtual Congress 2020 – Respiratory critical care
Year: 2020


Quantitative CT for the assessment of disease severity in interstitial lung disease
Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Year: 2020


Murine models of cardiovascular damage in lung diseases
Source: Eur Respir Monogr 2020; 88: 31-46
Year: 2020


Determination of pulmonary hypertension degree in patients with interstitial lung diseases
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010

Frequency and impact of interstitial lung disease on clinical state and mortality in systemic scleroderma
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012